Literature DB >> 7979683

Orthotopic heart transplantation with bicaval and pulmonary venous anastomoses.

C Blanche1, M Valenza, L S Czer, P Barath, D Admon, D Harasty, C Utley, D Freimark, I Aleksic, J Matloff.   

Abstract

We present our experience with an alternative technique for orthotopic heart transplantation. It consists of total excision of the recipient's atria, with the donor's heart implantation performed using bicaval end-to-end anastomoses as well as pulmonary venous anastomoses. Forty consecutive patients receiving transplants in this fashion were compared with 64 patients who underwent orthotopic transplantation with the standard technique. The incidence of postoperative tricuspid regurgitation was reduced in patients receiving transplants with the new surgical approach (p = 0.003). In addition, the need for pacemaker implantation for severe bradyarrhythmia in the early (0 to 6 weeks) posttransplantation period (p = 0.003) was eliminated. Although not statistically significant, there was a trend in the reduction of postoperative mitral regurgitation in patients who received transplants by the modified technique. Based on this experience, we believe this modified technique for orthotopic heart transplantation has an anatomic and physiologic advantage that may improve long-term hemodynamic results.

Entities:  

Mesh:

Year:  1994        PMID: 7979683     DOI: 10.1016/0003-4975(94)91944-5

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

1.  Mechanisms of transplant right ventricular dysfunction.

Authors:  P Van Trigt; H B Bittner; S W Kendall; C A Milano
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

2.  Combined Heart and Kidney Transplantation: Clinical Experience in 100 Consecutive Patients.

Authors:  Morcos Atef Awad; Lawrence S C Czer; Dominic Emerson; Stanley Jordan; Michele A De Robertis; James Mirocha; Evan Kransdorf; David H Chang; Jignesh Patel; Michelle Kittleson; Danny Ramzy; Joshua S Chung; J Louis Cohen; Fardad Esmailian; Alfredo Trento; Jon A Kobashigawa
Journal:  J Am Heart Assoc       Date:  2019-02-19       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.